106 related articles for article (PubMed ID: 32724387)
1. AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner.
Jian L; Xie J; Guo S; Yu H; Chen R; Tao K; Yang C; Li K; Liu S
Oncol Lett; 2020 Aug; 20(2):1441-1451. PubMed ID: 32724387
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer.
Jiang R; Sun Y; Chen X; Shi P
Breast Cancer Res Treat; 2021 Nov; 190(2):203-211. PubMed ID: 34519905
[TBL] [Abstract][Full Text] [Related]
3. Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.
Obacz J; Brychtova V; Podhorec J; Fabian P; Dobes P; Vojtesek B; Hrstka R
Onco Targets Ther; 2015; 8():1523-32. PubMed ID: 26170690
[TBL] [Abstract][Full Text] [Related]
4. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
5. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
6. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
7. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
8. Anterior Gradient 3 Promotes Breast Cancer Development and Chemotherapy Response.
Xu Q; Shao Y; Zhang J; Zhang H; Zhao Y; Liu X; Guo Z; Chong W; Gu F; Ma Y
Cancer Res Treat; 2020 Jan; 52(1):218-245. PubMed ID: 31291711
[TBL] [Abstract][Full Text] [Related]
9. Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.
Yu H; Yang C; Jian L; Guo S; Chen R; Li K; Qu F; Tao K; Fu Y; Luo F; Liu S
Oncol Rep; 2019 Aug; 42(2):826-838. PubMed ID: 31173262
[TBL] [Abstract][Full Text] [Related]
10. Extracellular AGR3 regulates breast cancer cells migration via Src signaling.
Obacz J; Sommerova L; Sicari D; Durech M; Avril T; Iuliano F; Pastorekova S; Hrstka R; Chevet E; Delom F; Fessart D
Oncol Lett; 2019 Nov; 18(5):4449-4456. PubMed ID: 31611954
[TBL] [Abstract][Full Text] [Related]
11. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
12. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
Lee WS; Park SY; Park YL; Joo YE
In Vivo; 2023; 37(1):483-489. PubMed ID: 36593009
[TBL] [Abstract][Full Text] [Related]
14. Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.
Tang CK; Concepcion XZ; Milan M; Gong X; Montgomery E; Lippman ME
Cancer Res; 1999 Oct; 59(20):5315-22. PubMed ID: 10537315
[TBL] [Abstract][Full Text] [Related]
15. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Bjørklund SS; Kristensen VN; Seiler M; Kumar S; Alnæs GI; Ming Y; Kerrigan J; Naume B; Sachidanandam R; Bhanot G; Børresen-Dale AL; Ganesan S
BMC Cancer; 2015 Jul; 15():524. PubMed ID: 26183823
[TBL] [Abstract][Full Text] [Related]
16. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
[TBL] [Abstract][Full Text] [Related]
18. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
